Trials / Suspended
SuspendedNCT00768027
Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- HyperMed · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate wound healing progression using a new hyperspectral imaging technology.
Detailed description
The purpose of this clinical study is to define patient eligibility for hyperbaric oxygen therapy (HBOT) and to evaluate wound healing progression during HBOT using a new hyperspectral imaging technology (OxyVu).
Conditions
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2008-10-07
- Last updated
- 2009-06-04
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00768027. Inclusion in this directory is not an endorsement.